Medline’s IPO underscores broad investor urge for food for a sleepy nook of the healthcare enterprise
Last Updated:
First Published:
Forget weight-loss drugs and the latest development for their makers — the hottest healthcare stock right now makes those ubiquitous striped blankets for newborns and offers more than 300,000 other medical and surgical products.
Medline’s stock
MDLN soared 41% above its IPO price on Wednesday. That was the best offer-to-close price performance since diagnostics company BillionToOne BLLN rose 82% on its first day of trading Nov. 6.